Article info
Therapeutics
Randomised controlled trial
Initial treatment of hypertension with aliskiren and amlodipine combination gives 6.5 mm Hg greater reduction in systolic BP than does either monotherapy
- Correspondence to John M Flack
Department of Medicine, University Health Center, Suite 2E, Wayne State University, Detroit, MI 48201, USA; jflack{at}med.wayne.edu
Citation
Initial treatment of hypertension with aliskiren and amlodipine combination gives 6.5 mm Hg greater reduction in systolic BP than does either monotherapy
Publication history
- First published August 18, 2011.
Online issue publication
June 03, 2021
Article Versions
- Previous version (3 June 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions